Research Progress on Anti-Inflammatory Effects and Related Mechanisms of Astragalin

Jingya Ruan,Zhongwei Shi,Xiaoyan Cao,Zhunan Dang,Qianqian Zhang,Wei Zhang,Lijie Wu,Yi Zhang,Tao Wang

DOI: https://doi.org/10.3390/ijms25084476

IF: 5.6

2024-04-20

International Journal of Molecular Sciences

Abstract:Chronic inflammation is a significant contributor to the development of cancer, cardiovascular disease, diabetes, obesity, autoimmune disease, inflammatory bowel disease, and other illnesses. In the academic field, there is a constant demand for effective methods to alleviate inflammation. Astragalin (AST), a type of flavonoid glycoside that is the primary component in several widely used traditional Chinese anti-inflammatory medications in clinical practice, has garnered attention from numerous experts and scholars. This article focuses on the anti-inflammatory effects of AST and conducts research on relevant literature from 2003 to 2023. The findings indicate that AST demonstrates promising anti-inflammatory potential in various models of inflammatory diseases. Specifically, AST is believed to possess inhibitory effects on inflammation-related factors and protein levels in various in vitro cell models, such as macrophages, microglia, and epithelial cells. In vivo studies have shown that AST effectively alleviates neuroinflammation and brain damage while also exhibiting potential for treating moderate diseases such as depression and stroke; it also demonstrates significant anti-inflammatory effects on both large and small intestinal epithelial cells. Animal experiments have further demonstrated that AST exerts therapeutic effects on colitis mice. Molecular biology studies have revealed that AST regulates complex signaling networks, including NF-κB, MAPK, JAK/STAT pathways, etc. In conclusion, this review will provide insights and references for the development of AST as an anti-inflammatory agent as well as for related drug development.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The main purpose of this paper is to explore the anti-inflammatory effects of astragalin (AST) and its related mechanisms. Specifically, the paper systematically analyzes the anti-inflammatory effects of AST in different inflammation models by reviewing relevant literature from 2003 to 2023 and investigates its molecular mechanisms. The main focus includes the following aspects:

1. **Impact of Chronic Inflammation**: The paper points out that chronic inflammation is closely related to various diseases such as cancer, cardiovascular diseases, diabetes, obesity, autoimmune diseases, and inflammatory bowel disease, emphasizing the importance of effectively alleviating inflammation.

2. **Anti-inflammatory Potential of AST**: AST is a common natural flavonoid compound that has shown anti-inflammatory effects on various cell models (such as macrophages, microglia, and epithelial cells) in vitro. Specifically, it inhibits the production of inflammation-related factors (such as TNF-α, IL-1β, IL-6, etc.) and reduces the levels of related proteins.

3. **In Vivo Anti-inflammatory Effects**: In animal models, AST has been proven to effectively reduce neuroinflammation and brain injury, showing potential for treating depression and stroke. Additionally, it exhibits significant anti-inflammatory effects on both small and large intestinal epithelial cells and shows therapeutic effects in mouse models of colitis.

4. **Molecular Biological Mechanisms**: Molecular biology studies indicate that AST exerts its anti-inflammatory effects by regulating complex signaling networks (such as NF-κB, MAPK, JAK/STAT pathways, etc.).

In summary, this review aims to provide a reference for the research and development of AST as an anti-inflammatory agent.